Torimura Takuji 鳥村拓司

… Alternative Names

TORIMURA Takuji 鳥村拓司

島村拓司シマムラタクジ

Less

Researcher Number	60197986
Other IDs
External Links
Affiliation (Current)	2025: 久留米大学, 付置研究所, 客員教授
Affiliation (based on the past Project Information) *help	2022 – 2023: 久留米大学, 付置研究所, 客員教授 2013 – 2021: 久留米大学, 医学部, 教授 2011 – 2012: 久留米大学, 先端癌治療研究センター, 教授 2007 – 2010: Kurume University, 医学部, 准教授 2003 – 2006: 久留米大学, 医学部, 助教授 1999 – 2002: 久留米大学, 医学部, 講師 1990 – 1996: 久留米大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Gastroenterology / Gastroenterology / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Gastroenterology / Gastroenterology
Keywords	Principal Investigator 肝細胞癌 / 血管新生抑制 / Endostatin / 遺伝子治療 / K1-5 / Gene therapy / Kringle1-5 / cDNA / TNP-470 / 内皮細胞 … More / 血管新生抑制療法 / 血管内皮前駆細胞 / Germ free / サイトカイン / ケモカイン / リンパ球 / 血管新生阻害剤 / 腫瘍免疫 / シンバイオティックス / 抗腫瘍効果 / 免疫チェックポイント阻害剤 / 腸内細菌叢 / バイオマーカー / CpG island / CpGアイランド / DNAメチル化 / 肝発がん / 非癌部肝組織 / DNAメチル化異常 / 多中心性再発 / Retrovirus / Kringle 1-5 / Endothelial progenitor cell / Anti-angiogenesis / Hepatocellular Carcinoma / トランスジェニックマウス / 骨髄移植 / レトロウイルス / エンドスタチン / Nude mouse / Hepatoma / Liposome / Damage of endothelial cell / PCR / プラスミド / 遺伝子銃 / endostatin / ヌードマウス / 肝癌細胞 / リポゾーム / 内皮細胞障害 / Krinde1-5 / inhibition of angiogenesis / hepatocellular carcinoma / 肺転移抑制 / 血管内皮細胞 / マイクロＲＮＡ / 血管新生 / マイクロRNA / CXCE4 / 細胞遊走能 / ベクター細胞 / αSMA / 平滑筋細胞 / 可溶性VEGFレセプター1,2 / siRNA / CXCR4遺伝子 / αSMA陽性細胞 / iPS細胞 / HIF1-alpha / 可用性VEGF レセプター / 間葉系幹細胞 / iPS 細胞 / 血管新生抑制遺伝子療法 / Soluble flk-1 / ウイルス / 移植再生医療 / 遺伝子 / 平滑筋前駆細胞 / 骨髄細胞 / VEGF / flk-1 / 転移 / 接着因子 … More Except Principal Investigator 肝硬変 / PYY_<3-36> / NASH / ATP7B / 脂肪肝 / IL-1 / COX2 / angiopoietin-1 / Tie-2 / 肝細胞癌 / endothelin-1 / 類洞内皮細胞 / ミオシン / アクチン / エンドセリン-1 / Oxidative stress / Fatty liver / 酸化ストレス / Inclusion body / Mallory body / Cooper / Wilson disease / プロテアソーム / ユビキチン / 中間径フィラメント / プロテアソームゴルジ装置 / aggresome / マロリー体 / 中間系線維 / 細胞内凝集体 / Mallory体 / 銅 / ウイルソン病 / HEPATITIS C VIRUS / LIPOMICS / DEDIFFERENTIATION / PPAR α ACTIVATOR / HEPATOMA CELL / HEPATIC STELLATE CELL / フィノフィブレート / PPARγ / 肝細胞脂肪変性 / 肝発癌 / transgenic mouse / HCV-Core蛋白 / フェノフィブレート / PPARα / C型肝炎ウイルス / Lipomics / 脱分化 / PPARα activator / 肝癌細胞 / 肝星細胞 / angiogenesis / hepatocellular carcinoma / 血管新生 / angiopoietin-2 / angiopojetin-1 / Liver cirrhosis / CD-44 / Hyaluronic acid receptor / Hyaluronic acid / Sinusoidal endothelial cell / liver injury / インターフェロン治療 / C型慢性肝炎 / 肝類洞内皮細胞 / 肝線維化 / CD44 / ヒアルロン酸レセプター / ヒアルロン酸 / 慢性肝障害 / nitric oxide / alpha-smooth muscle actin / endothelin-1 receptor / hepatic stellate cell (Ito cell) / hepatic sinusoidal microcirculation / liver cirrhosis / エンドセリン-I / VIP / サブスタンス-P / デスミン / インターロイキン1β / エンドセリン-1リセプター / 神経終末 / 一酸化窒素 / α-平滑筋アクチン / エンドセリン-1レセプター / 伊東細胞 / 肝類洞微小循環 / calmodulin / myosin / Actin / substance P / hepatic microcirculation / contraction / Ito cell (Fat-storing cell) / レセプタ- / サブスタンスーP / エンドセリンー1 / 伊東細胞(Fatーstoring cell) / カルモジュリン / サブスタンスP / 肝微小循環 / 収縮 / 伊東細胞(Fat-storing cell) Less

The investigation of factors influencing on therapeutic effect of anti-PD-1 antibody therapy for hepatocellular carcinoma by comprehensive analysis of intestinal floraPrincipal Investigator
- Principal Investigator
  
  Torimura Takuji
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kurume University
DNA methylation level of 10 CpG sites on 8 specific genes in non-cancerous liver tissues is useful to predict multicentric recurrence of hepatocellular carcinoma after surgical resectionPrincipal Investigator
- Principal Investigator
  
  Torimura Takuji
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Development of new antiangiogenic therapy specific for tumor tissue of hepatocellular carcinoma with microRNAPrincipal Investigator
- Principal Investigator
  
  Torimura Takuji
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Development of iPS cells-derived vector cells for antiangiogenic gene therapy for hepatocellular carcinoma.Principal Investigator
- Principal Investigator
  
  TORIMURA Takuji
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Antiangiogenic gene therapy for hepatocellular carcinoma with bone marrow-derived progenitor cellsPrincipal Investigator
- Principal Investigator
  
  TORIMURA Takuji
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Research for usefulness of intestinal peptide, PYY_<3-36> for therapeutic agents of fatty liver and NASH
- Principal Investigator
  
  UENO Takato
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Gene Transfer of Endostatin cDNA to Bone Marrow Cells of Mice with Hepatocellular CarcinomaPrincipal Investigator
- Principal Investigator
  
  TORIMURA Takuji
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Biological significance of the expression of a Wilson disease mutant protein
- Principal Investigator
  
  HARADA Masaru
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
ROLE OF PPARα HUMAN HEPATIC STELLATE CELL AND HEPATOMA CELL
- Principal Investigator
  
  UENO Takato
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  KURUME UNIVERSITY
The role of Angiopoietin-1,2, and Tie-2 on angiogenesis in hepatocellular carcinoma.
- Principal Investigator
  
  HARADA Riko, 金基哲
- Project Period (FY)
  1999 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University School of Medicine
Gene transfer of Endostatin and K1-5 suppresses the growth of hepatocellular carcinomaPrincipal Investigator
- Principal Investigator
  
  TORIMURA Takuji
- Project Period (FY)
  1999 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  KURUME UNIVERSITY
Inhibitory effect of the angiogenesis inhibitor TNP-470 on hepatocellular carcinomasPrincipal Investigator
- Principal Investigator
  
  TORIMURA Takuji
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Study of cells and peptides controling the hepatic sinusoidal blood flow
- Principal Investigator
  
  TANIKAWA Kyuichi
- Project Period (FY)
  1994 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Evaluation of hyaluronic acid as a marker of hepatic sinusoidal endothelial cell disorder in chronic liver injury
- Principal Investigator
  
  UENO Takato
- Project Period (FY)
  1994 – 1995
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
肝細胞癌の血管内転移の機序に関する各種細胞接着因子及びその抗体を用いた検討Principal Investigator
- Principal Investigator
  
  鳥村拓司
- Project Period (FY)
  1993
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Morphologic study on Ito cell (Fat-storing cell) contractility
- Principal Investigator
  
  UENO Takato
- Project Period (FY)
  1990 – 1992
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University

[Book] ラムシルマブによる肝細胞癌治療2020
- Author(s)
  鳥村拓司、中野聖士、岩本英希
- Total Pages
  223
- Publisher
  アークメディア
- ISBN
  9784875832379
- Data Source
  KAKENHI-PROJECT-19K07788
[Book] 肝癌診療マニュアル2020
- Author(s)
  鳥村拓司、長谷川潔、泉並木、工藤正俊
- Total Pages
  278
- Publisher
  医学書院
- ISBN
  9784260040815
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors. Cancer Communications.2023
- Author(s)
  Suzuki H, Iwamoto H, Seki T, Nakamura T, Masuda A, Sakaue T, Tanaka T, Imamura Y, Niizeki T, Nakano M, Shimose S, Shirono T, Noda Y, Kamachi N, Sakai M, Morita K, Nakayama M, Yoshizumi T, Kuromatsu R, Yano H, Cao Y, Koga H, Torimura T.
- Journal Title
  
  Cancer Communications.
  
  Volume: 43 Issue: 4 Pages: 415-434
- DOI
  10.1002/cac2.12411
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] The Beneficial Impact of MAFLD on Lenvatinib Treatment in Patients with Non-viral Hepatocellular Carcinoma.2023
- Author(s)
  Shimose S, Hiraoka A, Casadei-Gardini A, Tsutsumi T, Nakano D, Iwamoto H, Tada F, Rimini M, Tanaka M, Torimura T, Suga H, Ohama H, Burgio V, Niizeki T, Moriyama E, Suzuki H, Shirono T, Noda Y, Kamachi N, Nakano M, Kuromatsu R, Koga H, Kawaguchi T.
- Journal Title
  
  Hepatology Research.
  
  Volume: 53 Issue: 2 Pages: 104-115
- DOI
  10.1111/hepr.13843
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.2023
- Author(s)
  Shimose S, Iwamoto H, Niizeki T, Tanaka M, Shirono T, Moriyama E, Noda Y, Nakano M, Suga H, Kuromatsu R, Torimura T, Koga H, Kawaguchi T.
- Journal Title
  
  International journal of molecular sciences.
  
  Volume: 24 Issue: 18 Pages: 13715-13715
- DOI
  10.3390/ijms241813715
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells2023
- Author(s)
  Tanaka T, Koga H, Suzuki H, Iwamoto H, Sakaue T, Masuda A, Nakamura T, Akiba J, Yano H, Torimura T, Kawaguchi T.
- Journal Title
  
  Hepatol Int.
  
  Volume: 8 Issue: 3 Pages: 984-997
- DOI
  10.1007/s12072-023-10572-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)2023
- Author(s)
  Hasegawa K、Takemura N、Yamashita T、Watadani T、Kaibori M、Kubo S、Shimada M、Nagano H、Hatano E、Aikata H、Iijima H、Ueshima K、Ohkawa K、Genda T、Tsuchiya K、Torimura T、Ikeda M、Furuse J、Akahane M、Kobayashi S、Sakurai H、Takeda A、Murakami T、Motosugi U、Matsuyama Y、Kudo M、Tateishi R
- Journal Title
  
  Hepatology Research
  
  Volume: 53 Issue: 5 Pages: 383-390
- DOI
  10.1111/hepr.13892
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08199, KAKENHI-PROJECT-19K07788
[Journal Article] Kurume Med J.2023
- Author(s)
  Goto Y, Niizeki T, Fukutomi S, Shirono T, Shimose S, Iwamoto H, Kojima S, Kanno H, Uchino Y, Sasaki S, Shirahama N, Muroya D, Nomura Y, Akashi M, Nakayama G, Hirakawa Y, Sato T, Yoshitomi M, Sakai H, Hisaka T, Kakuma T, Koga H, Torimura T, Akagi Y, Okuda K.
- Journal Title
  
  Kurume Med J.
  
  Volume: 68 Pages: 239-245
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.2022
- Author(s)
  Shirono T, Iwamoto H, Niizeki T, Shimose S, Kajiwara A, Suzuki H, Kamachi N, Noda Y, Okamura S, Nakano M, Kuromatsu R, Murotani K, Koga H, Torimura T.
- Journal Title
  
  Hepatology Communications.
  
  Volume: 6 Issue: 9 Pages: 2594-2604
- DOI
  10.1002/hep4.2016
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.2022
- Author(s)
  Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Tani J, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Tanaka S, Deguchi A, Shimose S, Shirono T, Sakai M, Suzuki H, Moriyama E, Koga H, Torimura T, Kawaguchi T, New Fp Study Group, Kurume Liver Cancer Study Group of Japan.
- Journal Title
  
  Cancers.
  
  Volume: 14 Issue: 19 Pages: 4873-4873
- DOI
  10.3390/cancers14194873
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma.2022
- Author(s)
  Shimose S, Hiraoka A, Tanaka M, Iwamoto H, Tanaka T, Noguchi K, Aino H, Yamaguchi T, Itano S, Suga H, Niizeki T, Moriyama E, Shirono T, Noda Y, Kamachi N, Okamura S, Nakano M, Kawaguchi T, Kuromatsu R, Koga H, Torimura T.
- Journal Title
  
  Scientific Reports.
  
  Volume: 12 Issue: 1 Pages: 17018-17018
- DOI
  10.1038/s41598-022-21528-2
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice2021
- Author(s)
  Iwamoto H, Shimose S, Noda Y, Shirono T, Niizeki T, Nakano M, Okamura S, Kamachi N, Suzuki H, Sakai M, Kajiwara A, Itano S, Tanaka M, Yamaguchi T, Kuromatsu R, Koga H, Torimura T andon behalf of The Kurume Liver Cancer Study Group of Japan
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 11 Pages: 2786-2786
- DOI
  10.3390/cancers13112786
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion2021
- Author(s)
  Niizeki T, Iwamoto H, Shirono T, Shimose S, Nakano M, Okamura S, Noda Y, Kamachi N, Hiroyuki S, Sakai M, Kuromatsu R, Koga H and Torimura T
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 17 Pages: 4550-4550
- DOI
  10.3390/cancers13174450
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] "First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study "2021
- Author(s)
  Shimose S, Hiraoka A, Nakano M, Iwamoto H, Tanaka M, Tanaka T, Noguchi K, Aino H, Ogata K, Kajiwara M, Itano S, Yokokura Y, Yamaguchi T, Kawano H, Matsukuma N, Suga H, Niizeki T, Shirono T, Noda Y, Kamachi N, Okamura S, Kawaguchi T, Koga H, Torimura T
- Journal Title
  
  Cancer Medicine
  
  Volume: 10 Issue: 23 Pages: 8530-8541
- DOI
  10.1002/cam4.4367
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma2021
- Author(s)
  Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T, Kurume Liver Cancer Study Group of Japan
- Journal Title
  
  ESMO Open
  
  Volume: 6 Issue: 1 Pages: 100020-100020
- DOI
  10.1016/j.esmoop.2020.100020
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study2021
- Author(s)
  Shimose S, Iwamoto H, Tanaka M, Niizeki T, Shirono T, Noda Y, Kamachi N, Okamura S, Nakano M, Suga H, Yamaguchi T, Kawaguchi T, Kuromatsu R, Noguchi K, Koga H, Torimura T
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 1 Pages: 160-160
- DOI
  10.3390/cancers13010160
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma2021
- Author(s)
  Iwamoto H, Niizeki T, Nagamatsu H, Shimose S, Shirono T, Nakano M, Okamura S, Noda Y, Kamachi N, Sakai M, Suzuki H, Kuromatsu R, Kawaguchi A, Koga H, Torimura T,et al.
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 4 Pages: 646-646
- DOI
  10.3390/cancers13040646
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Primary Treatment with Molecular-Targeted Agents for Hepatocellular Carcinoma: A Propensity Score-matching Analysis.2020
- Author(s)
  14Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T.
- Journal Title
  
  Hepatology Communications.
  
  Volume: 4 Issue: 8 Pages: 1218-1228
- DOI
  10.1002/hep4.1535
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Impact of Decorin on the Physical Function and Prognosis of Patients with　Hepatocellular Carcinoma.2020
- Author(s)
  6Kawaguchi T, Yoshio S, Sakamoto Y, Hashida R, Koya S, Hirota K, Nakano D, Yamamura S, Niizeki T, Matsuse H, Torimura T.
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 9 Issue: 4 Pages: 936-936
- DOI
  10.3390/jcm9040936
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events2020
- Author(s)
  Iwamoto Hideki、Suzuki Hiroyuki、Shimose Shigeo、Niizeki Takashi、Nakano Masahito、Shirono Tomotake、Okamura Shusuke、Noda Yu、Kamachi Naoki、Nakamura Toru、Masuda Atsutaka、Sakaue Takahiko、Tanaka Toshimitsu、Nakano Dan、Sakai Miwa、Yamaguchi Taizo、Kuromatsu Ryoko、Koga Hironori、Torimura Takuji
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 4 Pages: 1010-1010
- DOI
  10.3390/cancers12041010
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Indication of Suitable Transarterial Chemoembolization and Multikinase Inhibitors for Intermediate Stage Hepatocellular Carcinoma2020
- Author(s)
  Shimose S, Kawaguchi T, Iwamoto H, Niizeki T, Shirono T, Tanaka M, Koga H, Torimura T.
- Journal Title
  
  Oncol Lett.
  
  Volume: 19 Pages: 2667-2676
- DOI
  10.3892/ol.2020.11399
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Controlling Nutritional Status (CONUT) Score Is Associated With Overall Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Cohort Study2020
- Author(s)
  Shimose S, Kawaguchi T, Iwamoto H, Tanaka M, Miyazaki K, Ono M, Niizeki T, Shirono T, Okamura S, Nakano M, Suga H, Yamaguchi T, Yokokura Y, Noguchi K, Koga H, Torimura T.
- Journal Title
  
  Nutrients
  
  Volume: 12 Issue: 4 Pages: 1076-1089
- DOI
  10.3390/nu12041076
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study2019
- Author(s)
  Ide T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, Nakamuta M, Oeda S, Eguchi Y, Shakado S, Sakisaka S, Yoshimaru Y, Sasaki Y, Honma Y, Harada M, Seike M, Maeshiro T, Miuma S, Nakao K, Mawatari S, Ido A, Nagata K, Matsumoto S, Takami Y, Sohda T, Kakuma T, Torimura T
- Journal Title
  
  Hepatol Int.
  
  Volume: 印刷中 Issue: 3 Pages: 293-301
- DOI
  10.1007/s12072-019-09939-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07988, KAKENHI-PROJECT-18K07945, KAKENHI-PROJECT-19K07788, KAKENHI-PROJECT-18H02798
[Journal Article] Prognostic Impact of Transcatheter Arterial Chemoembolization (TACE) Combined With Radiofrequency Ablation in Patients With Unresectable Hepatocellular Carcinoma: Comparison With TACE Alone Using Decision-Tree Analysis After Propensity Score Matching2019
- Author(s)
  Shimose S, Tanaka M, Iwamoto H, Niizeki T, Shirono T, Aino H, Noda Y, Kamachi N, Okamura S, Nakano M, Kuromatsu R, Kawaguchi T, Kawaguchi A, Koga H, Yokokura Y, Torimura T.
- Journal Title
  
  Hepatol Res.
  
  Volume: 49 Issue: 8 Pages: 919-928
- DOI
  10.1111/hepr.13348
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Journal Article] Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.2019
- Author(s)
  Nakano M, Koga H, Ide T, Kuromatsu R, Hashimoto S, Yatsuhashi H, Seike M, Higuchi N, Nakamuta M, Shakado S, Sakisaka S, Miuma S, Nakao K, Yoshimaru Y, Sasaki Y, Oeda S, Eguchi Y, Honma Y, Harada M, Nagata K, Mawatari S, Ido A, Maeshiro T, Matsumoto S, Takami Y, Sohda T, Torimura T
- Journal Title
  
  Cancer Med.
  
  Volume: 印刷中 Issue: 5 Pages: 2646-2653
- DOI
  10.1002/cam4.2061
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07988, KAKENHI-PROJECT-18K07945, KAKENHI-PROJECT-19K07788, KAKENHI-PROJECT-18H02798
[Journal Article] Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.2018
- Author(s)
  Ikeda M, Kudo M, Aikata H, Nagamatsu H, Ishii H, Yokosuka O, Torimura T, Morimoto M, Ikeda K, Kumada H, Sato T, Kawai I, Yamashita T, Horio H, Okusaka T; Miriplatin TACE Study Group
- Journal Title
  
  J Gastroenterol
  
  Volume: 53 Issue: 2 Pages: 281-290
- DOI
  10.1007/s00535-017-1374-6
- NAID
  120006878534
- Open Access
- Data Source
  KAKENHI-PROJECT-16K09385
[Journal Article] Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease.2017
- Author(s)
  Koya S, Kawaguchi T, Hashida R, Goto E, Matsuse H, Saito H, Hirota K, Taira R, Matsushita Y, Imanaga M, Nagamatsu A, Shirono T, Shimose S, Iwamoto H, Niizeki T, Kuromatsu R, Miura H, Shiba N, Torimura T.
- Journal Title
  
  Hepatol Res
  
  Volume: 47 Issue: 3
- DOI
  10.1111/hepr.12718
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09385
[Journal Article] STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.2017
- Author(s)
  Abe M, Yoshida T, Akiba J, Ikezono Y, Wada F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, Sata M, Koga H, Yoshimura A, Torimura T.
- Journal Title
  
  World J Gastroenterol
  
  Volume: 23 Issue: 37 Pages: 6833-6844
- DOI
  10.3748/wjg.v23.i37.6833
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09385, KAKENHI-PROJECT-17K08776
[Journal Article] Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma2016
- Author(s)
  Okamura S, Sumie S, Tonan T, Nakano M, Satani M, Shimose S, Shirono T, Iwamoto H, Aino H, Niizeki T, Tajiri N, Kuromatsu R, Okuda K, Nakashima O, Torimura TOkamura S, Sumie S, Tonan T, Nakano M, Satani M, Shimose S, Shirono T, Iwamoto H, Aino H, Niizeki T, Tajiri N, Kuromatsu R, Okuda K, Nakashima O, Torimura T
- Journal Title
  
  Dig Liver Dis
  
  Volume: 48 Pages: 945-952
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09385
[Journal Article] Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.2016
- Author(s)
  Torimura T, Iwamoto H, Nakamura T, Abe M, Ikezono Y, Wada F, Sakaue T, Masuda H, Hashimoto O, Koga H, Ueno T, Yano H.
- Journal Title
  
  Neoplasia
  
  Volume: 18 Issue: 7 Pages: 413-424
- DOI
  10.1016/j.neo.2016.05.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-16K09385
[Journal Article] Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study.2016
- Author(s)
  Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Satani M, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Koga H, Torimura T; Kurume Liver Cancer Study Group Of Japan.
- Journal Title
  
  Oncotarget
  
  Volume: 7 Issue: 39 Pages: 64400-64409
- DOI
  10.18632/oncotarget.10794
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-16K09385
[Journal Article] The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis2016
- Author(s)
  Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Okamura S, Shimose S, Miyahara K, Torimura T
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 5 Issue: 1 Pages: 83-88
- DOI
  10.3892/mco.2016.879
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09385
[Journal Article] Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.2015
- Author(s)
  Sumie S, Kawaguchi T, Kawaguchi A, Kuromatsu R, Nakano M, Torimura T et al.
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 3 Pages: 115-120
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25461018
[Journal Article] Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces "angiogenic switch off" in a hepatoma mouse model.2015
- Author(s)
  Iwamoto H, Nakamura T, Koga H, Izaguirre-Carbonell J, Kamisuki S, Sugawara F, Abe M, Iwabata K, Ikezono Y, Sakaue T, Masuda A, Yano H, Ohta K, Nakano M, Shimose S, Shirono T, Torimura T.
- Journal Title
  
  Molecular Therapy Oncolytics
  
  Volume: 2 Pages: 15020-15020
- DOI
  10.1038/mto.2015.20
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-15K07419, KAKENHI-PROJECT-25461018
[Journal Article] Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.2015
- Author(s)
  Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Tajiri N, Satani M, Niizeki T, Aino H, Okamura S, Iwamoto H, Shimose S, Shirono T, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan.
- Journal Title
  
  Cancer Medicine
  
  Volume: 12 Issue: 12 Pages: 1836-1843
- DOI
  10.1002/cam4.548
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-25461018
[Journal Article] Effects of fucoidan on proliferation, AMP-activated protein kinase, and downstream metabolism- and cell cycle-associated molecules in poorly differentiated human hepatoma HLF cells.2015
- Author(s)
  Kawaguchi T, Hayakawa M, Koga H, Torimura T.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 46 Issue: 5 Pages: 2216-2222
- DOI
  10.3892/ijo.2015.2928
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461025, KAKENHI-PROJECT-25461018
[Journal Article] PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.2015
- Author(s)
  Iwamoto H, Zhang Y, Seki T, Yang Y, Nakamura M, Wang J, Yang X, Torimura T, Cao Y
- Journal Title
  
  Science Advances
  
  Volume: 1 Issue: 3 Pages: 1-14
- DOI
  10.1126/sciadv.1400244
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25461018
[Journal Article] Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma2013
- Author(s)
  Torimura T, Iwamoto H, Nakamura T, Koga H, Ueno T, Kerbel RS, Sata M
- Journal Title
  
  Transl Oncol
  
  Volume: 6 Pages: 511-519
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461018
[Journal Article] Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusionchemotherapy.2012
- Author(s)
  Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, Aino H, Nakano M, Kawaguchi A, Kakuma T, Sata M.
- Journal Title
  
  J Gastroenterol.
  
  Volume: 47 Issue: 6 Pages: 686-695
- DOI
  10.1007/s00535-012-0555-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of5-fluorouracil-sensitive liver cancer in mice.2012
- Author(s)
  Torimura T, Ueno T, Taniguchi E, Masuda H, Iwamoto H, Nakamura T, Inoue K, Hashimoto O, Abe M, Koga H, Barresi V, Nakashima E, Yano H, Sata M.
- Journal Title
  
  Cancer Sci.
  
  Volume: 103 Issue: 3 Pages: 542-548
- DOI
  10.1111/j.1349-7006.2011.02182.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice2012
- Author(s)
  Inoue K, Torimura T, Nakamura T,Iwamoto H, Masuda H, Abe M, Hashimoto O, Koga H, Ueno T, Yano H, Sata M.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: 18 Issue: 14 Pages: 3924-3933
- DOI
  10.1158/1078-0432.ccr-11-2041
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclearfactor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions.2012
- Author(s)
  Abe M, Koga H, Yoshida T, Masuda H, Iwamoto H, Sakata M, Hanada S, Nakamura T, Taniguchi E, Kawaguchi T, Yano H, Torimura T, Ueno T, Sata M.
- Journal Title
  
  Hep Res.
  
  Volume: 42 Issue: 6 Pages: 591-600
- DOI
  10.1111/j.1872-034x.2011.00953.x
- NAID
  10031144274
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Total and high molecular weight adiponectin and hepatocellular carcinoma with HCVinfection.2011
- Author(s)
  Sumie S, Kawaguchi T, Kuromatsu R, Takata A, Nakano M, Satani M, Yamada S, Niizeki T, Torimura T, Sata M.
- Journal Title
  
  PLoS One.
  
  Volume: 6 Pages: 26840-26840
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma2011
- Author(s)
  Iwamoto H, Torimura T, Nakamura T, Hashimoto O, Inoue K, Kurogi J, Niizeki T, Kuwahara R, Abe M, Koga H, Yano H, Kerbel RS, Ueno T, Sata M.
- Journal Title
  
  Neoplasia.
  
  Volume: 13 Pages: 187-197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Metronomic S-1 chemotherapy and vandetanib : an efficacious and non-toxic treatment for hepatocellular carcinoma2011
- Author(s)
  Takuji Torimura, et al.
- Journal Title
  
  Neoplasia
  
  Volume: 13 Pages: 187-197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] HCC develops even in the early stage of chronic liver disease in elderly patients with HCVinfection.2010
- Author(s)
  Takata A, Kuromatsu R, Ando E, Iwamoto H, Fukushima N, Sumie S, Torimura T, Sata M.
- Journal Title
  
  Int J Mol Med.
  
  Volume: 26 Pages: 249-256
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article]2010
- Author(s)
  Nagamatsu H, Hiraki M, Mizukami N, Yoshida H, Iwamoto H, Sumie S, TorimuraT, Sata M.
- Journal Title
  
  Aliment Pharmacol Ther.
  
  Volume: 32 Issue: 4 Pages: 543-550
- DOI
  10.1111/j.1365-2036.2010.04379.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan2010
- Author(s)
  Nakano M, Ando E, Kuromatsu R, Torimura T, Sumie S, Takata A, Fukushima N, Kurogi J, Niizeki T, Iwamoto H, Tanaka M, Sata M.
- Journal Title
  
  HepatolRes.
  
  Volume: 40 Pages: 989-996
- NAID
  10027821216
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590752
[Journal Article] Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue2009
- Author(s)
  Ueno T, Torimura T, Nakamura T, et al.
- Journal Title
  
  Int J Mol Med. 24
  
  Pages: 17-22
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.2009
- Author(s)
  Ueno T, Torimura T, Nakamura T, et al.2番目
- Journal Title
  
  Int J Mol Med. 24
  
  Pages: 17-22
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Validating a markov model of treatment for hepatitis C virus-related Hepatocellular carcinoma2008
- Author(s)
  Ishida H, Oka M, Torimura T, et al.9番目
- Journal Title
  
  Method Inf med. 47
  
  Pages: 529-540
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Significance and therapeutic potential of endothelial progenitorcell transplantation in a cirrhotic liver rat model.2007
- Author(s)
  Nakamura T., Torimura T., Ueno T, et al.2番目
- Journal Title
  
  Gastroenterology. 133
  
  Pages: 91-107
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Hyperplastic nodular hepatic lesions following endo-to-side portacaval shunting in childfood.2007
- Author(s)
  Fukushima N, Kuromatsu R, Torimura T, et al.8番目
- Journal Title
  
  Intern. Med. 46
  
  Pages: 1203-1208
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Significance and therapeutic potential of endothelial progenitorcell transplantation in a cirrhotic liver rat model2007
- Author(s)
  T.Nakamura, T.Torimura, et. al.
- Journal Title
  
  Gastroenterology 133
  
  Pages: 91-107
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Serum C-reactive protein levels predict survival in hepatocellular carcinoma.2007
- Author(s)
  Nagaoka S, Yoshida T, Torimura T, et al.5番目
- Journal Title
  
  Liver Int. 27
  
  Pages: 1091-1097
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Sigrlificance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection2007
- Author(s)
  S.Sumie, T.Torimura, et. al.
- Journal Title
  
  Oncology Report 18
  
  Pages: 545-552
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.2007
- Author(s)
  Sumie S, Taniguchi E, Torimura T, et al.12番目
- Journal Title
  
  Oncol Rep. 18
  
  Pages: 545-552
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Serum C-reactive protein levels predict survival in hepatocellular carclnoma2007
- Author(s)
  S.Nagaoka, T.Torimura, et. al.
- Journal Title
  
  Liver International 27
  
  Pages: 1091-1097
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590796
[Journal Article] Gene Transfer of Kringle 1-5 Suppresses Tumor Development and Improves Prognosis of Mice with Hepatocellular Carcinoma2006
- Author(s)
  Takuji Torimura, et al.
- Journal Title
  
  Gastroenterology 130
  
  Pages: 1301-1310
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590700
[Journal Article] Gene Transfer of Kringle 1-5 Suppresses Tumor Development and Improves Probnosis of Mice with Hepatoccellular Carcinoma2006
- Author(s)
  Takuji Torimura, et al.
- Journal Title
  
  Gastroenterology 130(4)
  
  Pages: 1301-1310
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590700
[Journal Article] 肝癌の発生進展と血管新生2004
- Author(s)
  鳥村拓司, 上野隆登, 佐田通夫
- Journal Title
  
  肝胆膵 48(4)
  
  Pages: 491-498
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590700
[Journal Article] Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI902004
- Author(s)
  Ryuichiro Sakata, Takato Ueno, Toru Nakamura, Masaharu Sakamoto, Takuji Torimura, Michio Sata
- Journal Title
  
  J Hepatol 40
  
  Pages: 52-59
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590650
[Journal Article] Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma2004
- Author(s)
  Takuji Torimura, et al.
- Journal Title
  
  Journal of Hepatology 40
  
  Pages: 799-807
- Data Source
  KAKENHI-PROJECT-16590650
[Journal Article] Loposome-Mediated Gene Transfer of Kringle 1-5 Supress Tumor Development and Improves the Prognosis of Hepatocellular Carcinoma
- Author(s)
  Takuji Torimura, et al.
- Journal Title
  
  MEDICAL MOLECULAR MORPHOLOGY In prss
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590700
[Presentation] 諸条件下における進行肝細胞癌に対する薬物療法の最適治療を探る.2023
- Author(s)
  本理恵、新関　敬、鳥村拓司.
- Organizer
  JDDW　2023.
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] アテゾリズマブ・ベバシズマブ併用療法開始早期の単球増加不良は治療効果不良を予測しうる2022
- Author(s)
  鈴木浩之、岩本英希、下瀬茂男、新関　敬、中野聖士、城野智毅、野田　悠、蒲池直紀、山口泰三、中村　徹、増田篤高、田中俊光、黒松亮子、古賀浩徳、鳥村拓司.
- Organizer
  第58回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] . 肝動注化学療法の適応～New FP 療法の CR 予測因子からの考察～.2022
- Author(s)
  新関　敬、古賀浩徳、鳥村拓司
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 肝細胞癌のレンバチニブ薬剤耐性における癌線維芽細胞の HGF-cMET シグナルの重要性2022
- Author(s)
  岩本英希、古賀浩徳、鳥村拓司
- Organizer
  第108回日本消化器病学会総会.
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 抗PD-L1抗体による肝癌細胞増殖機構の解明.2022
- Author(s)
  田中俊光、古賀浩徳、鈴木浩之、岩本英希、阪上尊彦、増田篤高、中村徹、秋葉　純、矢野博久、鳥村拓司.
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 肝動注化学療法はアテゾリズマブ＋ベバシズマブ併用療法の奏効性を高める2022
- Author(s)
  岩本英希、鳥村拓司
- Organizer
  第58回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Circulating IGFBP-1 provides molecular targeted agent-resistance in hepatocellular carcinoma2021
- Author(s)
  Suzuki H, Iwamoto H, Nakamura T, Masuda A, Sakaue T, Tanaka T, Niizeki T, Okamura S, Shimose S, Shirono T, Noda Y, Kamachi N, Kuromatsu R, Koga H, Torimura T
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 進行肝細胞癌に対するアテゾリズマブ,ベバシズマブ併用療法の安全性と有効性の評価-多施設共同研究-2021
- Author(s)
  下瀬茂男、岩本英希、新関　敬、城野智毅、野田　悠、岡村修祐、古賀浩徳、鳥村拓司
- Organizer
  29th JDDW（第25回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 高齢者進行肝細胞癌に対するアテゾリズマブ及びベバシズマブ併用療法の使用経験2021
- Author(s)
  城野智毅、新関　敬、岩本英希、下瀬茂男、野田　悠、岡村修祐、古賀浩徳、鳥村拓司
- Organizer
  29th JDDW（第25回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] "INITIAL EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE"2021
- Author(s)
  Iwamoto H, Shimose S, Takashi N, Noda Y, Shirono T, Nakano M, Okamura S, Kamachi N, Suzuki H, Kuromatsu R, Koga H and Torimura T
- Organizer
  The Liver Meeting Digital Experience 2021（The 72th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)）
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 肝細胞癌に対する肝動注化学療法 New FP 療法とソラフェニブの治療成績の多施設後ろ向き比較研究2021
- Author(s)
  岩本英希、古賀浩徳、鳥村拓司
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Primary Treatment with Molecular-targeted Agents for Hepatocellular carcinoma: A Propensity Score-matching Analysis2021
- Author(s)
  Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 切除不能進行肝細胞癌に対するレンバチニブの造影超音波検査による早期効果判定の有用性2021
- Author(s)
  蒲池直紀、中野聖士、鳥村拓司
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] BCLC B 肝細胞癌におけるレンバチニブ療法の post-progression survival 及び post treatmentの検討2021
- Author(s)
  下瀬茂男、新関　敬、岩本英希、城野智毅、蒲池直紀、野田　悠、岡村修祐、中野聖士、黒松亮子、古賀浩徳、鳥村拓司
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] TACE不応肝細胞癌に対するレンバチニブ療法とrepeated TACEの有効性の比較　傾向スコアを用いて.2020
- Author(s)
  下瀬茂男、新関　敬、岩本英希、城野智毅、岡村修祐、中野聖士、高田晃男、田中正俊、古賀浩徳、鳥村拓司.
- Organizer
  28th JDDW（第24回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 造影CTにおける造影効果を含めた腫瘍因子からみたレンバチニブの治療効果について.2020
- Author(s)
  岡村修祐、下瀬茂男、新関　敬、蒲池直紀、野田　悠、城野智毅、岩本英希、中野聖士、黒松亮子、古賀浩徳、鳥村拓司.
- Organizer
  28th JDDW（第24回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Lenvatinibは腫瘍微小環境をimmune cold からhotへと変化させる.2020
- Author(s)
  鈴木浩之、岩本英希、鳥村拓司
- Organizer
  28th JDDW（第24回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 肝細胞癌（HCC）に対するBalloon-Occluded Transarterial Chemoembolization（B-TACE）とCoventional TACE（C-TACE）のTE4.2020
- Author(s)
  城野智毅、新関　敬、岩本英希、下瀬茂男、蒲池直紀、野田　悠、岡村修祐、中野聖士、黒松亮子、古賀浩徳、鳥村拓司.
- Organizer
  第56回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] 肝細胞癌に対する血管新生阻害剤の正常臓器血管への影響と癌血管特異的遺伝子の探索2020
- Author(s)
  岩本英希、古賀浩徳、鳥村拓司
- Organizer
  第106回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Involvement of WNT Signaling in Two-faced Actions of Claudin-2 in Liver Cancer Cells2019
- Author(s)
  Koga H, Imamura Y, Nakamura T, Iwamoto H, Sakaue T, Masuda A, Tanaka T, Nakano D, Suzuki H, Yano H and Torimura T
- Organizer
  The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Prognostic Indication of Transarterial Chemoembolization and Multikinase Inhibitors in Patients with Intermediate Stage Hepatocellular Carcinoma2019
- Author(s)
  Shimose S, Kawaguchi T, Iwamoto H, Niizeki T, Shirono T, Tanaka M, Koga H and Torimura T
- Organizer
  The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] A Comparative Study of Necrosis-inducing Effect on Hepatocellular Carcinoma: Balloon-Occluded VS. Conventional Transcatheter Arterial2019
- Author(s)
  Shirono T, Iwamoto H, Niizeki T, Shimose S, Koga H and Torimura T
- Organizer
  The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Real World Evidence of Lenvatinib in Adavanced Hepatocellular Carcinoma: A Multicenter Cohort Study2019
- Author(s)
  Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H and Torimura T
- Organizer
  The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] Lenvatinib Alters Tumor Immune Microenvironment from ‘COLD’ TO ‘HOT’ in Hepatocellular Carcinoma2019
- Author(s)
  Suzuki H, Iwamoto H, Tanaka T, Sakaue T, Masuda A, Nakamura T, Koga H and Torimura T
- Organizer
  The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07788
[Presentation] DNA methylation level of 10 CpG sites on 8 specific genes in non-cancerous liver tissues is useful to predict multicentric recurrence of hepatocellular carcinoma after surgical resection2018
- Author(s)
  Takuji Torimura, Hironori Koga, Toru Nakamura, Hideki Iwamoto, Yasuko Imamura, Hiroshi Suzuki, Takahiko Sakaue, Mitsuhiko Abe, Atsutaka Masuda, Toshimitsu Tanaka, Hirohisa Yano, Ken Yamamoto
- Organizer
  AASLD The liver meeting 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 非癌部肝組織のDNAメチル化の変化は肝細胞癌の多中心性発生のバイオマーカーになり得る2018
- Author(s)
  岩本英希　古賀浩徳　山本健　鳥村拓司
- Organizer
  第42回日本肝臓学会東部会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 当科における進行肝細胞癌に対する治療戦略2017
- Author(s)
  新関　敬, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 非Ｂ非Ｃ肝がん患者の長期生存に関連する因子2017
- Author(s)
  野田　悠, 川口　巧, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 血管新生抑制剤の中止は肝類洞のRevascularizationを引き起こす2017
- Author(s)
  岩本英希, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] Prognostic Impact of Fibroblast-derived Cytokine, IL-34 in Non-hepatitis B virus-, Non-hepatitis C virus-related Hepatocellular Carcinoma Patients with Chronic Liver Disease2017
- Author(s)
  Yu Noda, Kawaguchi T, Korenaga M, Nakano M, Niizeki T, Koga H,Kanto T, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] DAA治療開始後に肝細胞癌を発症したC型肝炎症例の検討2017
- Author(s)
  森田　俊, 永松洋明, 德重貴彦, 小岡洋平, 堤　翼, 平井真吾, 清水基規, 立石秀夫, 井出達也, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] HES1はWNTシグナル改変肝癌細胞においてスフィア形成能や造腫瘍能を決定的に制御する2017
- Author(s)
  古賀浩徳, 中村　徹, 和田史孝, 岩本英希, 増田篤高, 阪上尊彦, 田中俊光, 安倍満彦, 秋葉　純, 矢野博久, 鳥村拓司
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 当院における肉眼的脈管浸潤を伴う進行肝細胞癌に対する肝動注化学療法とsorafenibの比較2017
- Author(s)
  新関　敬, 中野聖士, 岩本英希, 下瀬茂男, 城野智毅, 相野　一, 黒松亮子, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] Prognosis of Patients with Non-hepatitis B virus-, Non-hepatitis C virus-related Hepatocellular Carcinoma: A Comparison with Hepatitis C virus-related Hepatocellular Carcinoma Patients2017
- Author(s)
  Noda, Kawaguchi T, Nakano M, Niizeki T, Kuromatsu R, Koga H, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] Targeting CD44v9-xCT system by sulfasalazine to overcome cisplatin resistance in human liver cancer cells2017
- Author(s)
  Wada F, Koga H, Jun Akiba, Yu Ikezono, Nakamura T, Abe M, Iwamoto H, Sakaue T, Masuda A, Tanaka T, Yano H, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 当院における肉眼的脈管浸潤を合併する進行肝細胞癌の予後因子と治療戦略2017
- Author(s)
  新関　敬, 古賀浩徳, 鳥村拓司
- Organizer
  第103回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 肝癌根治後DAA施行例における肝癌再発についての検討2017
- Author(s)
  黒松亮子, 井出達也, 中野聖士, 佐谷　学, 岡村修祐, 野田　悠, 有永照子, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] C-TACEとDEB-TACEの直接治療効果から、その選択を考察する2017
- Author(s)
  下瀬茂男, 新関　敬, 田中正俊, 城野智毅, 岩本英希, 野田　悠, 岡村修祐, 中野聖士, 佐谷　学, 黒松亮子, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] The Wnt Target Gene CLAUDIN-2 Regulates Tumorigenesis of Combined Hepatocellular- Cholangiocarcinoma Cells2017
- Author(s)
  Koga H, Imamura Y, Wada F, Ikezono Y, Abe M,, Iwamoto H, Nakamura T, Sakaue T, Tanaka T, Yano H, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 進行肝細胞癌に対するソラフェニブ治療の予後予測における肝線維化評価方法（FIB-4）の有用性2017
- Author(s)
  中野聖士, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] C型肝疾患でのDAAs-SVR例の肝発癌の検討2017
- Author(s)
  井出達也, 江口有一郎, 原田　大, 岩根伸治, 宮原千賀, 本間雄一, 有永照子, 宮島一郎, 桑原礼一郎, 天野恵介, 川口俊弘, 鳥村拓司
- Organizer
  25th JDDW（第21回日本肝臓学会大会）
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] Inhibition of hypoxia inducible factor via upregulation of von Hippel-Lindau protein induces ‘Angiogenic switch off’ in a mouse hepatoma model2017
- Author(s)
  Iwamoto H,, Koga H, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] ACE不応stage3肝癌症例へのDEB-TACE局所制御の検討2017
- Author(s)
  下瀬茂男, 新関　敬, 城野智毅, 岩本英希, 田中正俊, 古賀浩徳, 鳥村拓司
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] STAT3 deficiency prevents hepatocarcinogenesis and promotes transdifferentiation of hepatocytes into biliary cells in chronic liver injury of mice2017
- Author(s)
  be M, Yoshida T, Akiba J, Ikezono Y, Wada F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, Sata M, Koga H, Yoshimura A, Torimura T
- Organizer
  The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] マウス肝癌モデルを用いたNotch抑制剤の効果検討2016
- Author(s)
  岩本英希、鳥村拓司、古賀浩徳
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  ホテルニューオタニ幕張、他　千葉市
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 進行肝細胞癌に対するNew FP療法を中心とした集学的治療の検討：延命から治癒への挑戦2016
- Author(s)
  永松洋明、新関　敬、鳥村拓司
- Organizer
  第102回日本消化器病学会総会
- Place of Presentation
  京王プラザホテル　東京
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 脈管侵襲を有する進行肝細胞癌に対するNew FP療法：長期生存を目標としたCancer -Freeへの条件2016
- Author(s)
  永松洋明、新関　敬、鳥村拓司
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  ホテルニューオタニ幕張、他　千葉市
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] 進行肝細胞癌に対するソラフェニブ治療の予後予測におけるInflammation-based prognostic score (Glasgow prognostic score： GPS)の有用性2016
- Author(s)
  中野聖士、田中正俊、黒松亮子、永松洋明、古賀浩徳、鳥村拓司
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  ホテルニューオタニ幕張、他　千葉市
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] The Wnt effector T-CELL FACTOR-4 isoform activates Notch signaling via upregulating CLAUDIN-2 in human liver cancer cells2016
- Author(s)
  Koga H, Kim M, Imamua Y, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Sakaue T, Masuda A, Tanaka T, Yano H, Wands JR, Torimura T
- Organizer
  The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  Boston, USA
- Year and Date
  2016-11-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] DDP4阻害剤がNASHモデルマウスの肝癌におよぼす影響2016
- Author(s)
  川口　巧、谷口英太郎、鳥村拓司
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  ホテルニューオタニ幕張、他　千葉市
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] DNA methylation level of non-cancerous liver tissue has potential for being a biomarker of multicentric recurrence of hepatocellular carcinoma2016
- Author(s)
  Torimura T, Koga H, Nakamura T, Iwamoto H, Imamura Y, Ikezono Y, Sakaue T, Wada F, Masuda A, Tanaka T, Yano H, Ueno T, Yamamoto K
- Organizer
  The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  Boston, USA
- Year and Date
  2016-11-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] DPP4 inhibitor suppressed Warburg-Dickens pathway and HCC progression in a mouse model of NASH: A metabolomic analysis2016
- Author(s)
  Kawaguchi T, Taniguchi E, Koga H, Torimura T
- Organizer
  The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  Boston, USA
- Year and Date
  2016-11-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09385
[Presentation] Effects of sitagliptin, a dipeptidyl peptidase 4 inhibitor, on tumor2015
- Author(s)
  Kawaguchi T, Taniguchi E, Itou M, Oriishi T, Torimura T
- Organizer
  DDW 2015
- Place of Presentation
  ワシントン
- Year and Date
  2015-05-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] Expression of HES1, a Notch regulator of biliary features, is regulated by T-cell factor-4 isoforms2015
- Author(s)
  Koga H, Yano H, Torimura T
- Organizer
  第23回J DDW
- Place of Presentation
  東京
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] The SxxSS motif of T-cell factor-4 isoforms regulates Wnt5a expression and EMT in human liver caner cells2015
- Author(s)
  Koga H, Nakamura T, Abe M, Ikezono Y, Wada F, Torimura T et al.
- Organizer
  第106回アメリカ癌学会
- Place of Presentation
  フィラデルフィア
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] 肝癌における血管新生の重要性2015
- Author(s)
  岩本英希、古賀浩徳、鳥村拓司
- Organizer
  第47回日本臨床分子形態学会総会･学術集会
- Place of Presentation
  長崎
- Year and Date
  2015-09-18
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] 肝細胞癌における血管新生を標的とした分子標的治療の新知見2015
- Author(s)
  岩本英希、鳥村拓司
- Organizer
  第41回日本肝臓学会西部会
- Place of Presentation
  名古屋
- Year and Date
  2015-12-03
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] C型肝炎ウイルスcore蛋白は低酸素環境下においてNF-κB/HIF-1α軸を介してVEGFの発現を上昇させる.2012
- Author(s)
  安倍満彦、鳥村拓司
- Organizer
  第48回日本肝臓学会総会
- Place of Presentation
  金沢市
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] 肝細胞癌に対する血管新生抑制療法の試み。2012
- Author(s)
  鳥村拓司
- Organizer
  第67回久留米医学会総会
- Place of Presentation
  久留米市
- Year and Date
  2012-04-23
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] T-cell factor-4 isoforms regulate resistance involving upregulation of Bmi-1 in hepatocellular carcinoma cells2012
- Author(s)
  Koga Hironori, Torimura Takuji
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] C型肝炎ウイルスcore蛋白は低酸素環境下においてNF-κB/HIF-1α軸を介してVEGFの発現を上昇させる．2012
- Author(s)
  安倍満彦、鳥村拓司
- Organizer
  48回日本肝臓学会総会
- Place of Presentation
  金沢
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Anti-angiogenic Therapy Suppresses Tumor Growth of Hepatocellular Carcinoma2011
- Author(s)
  Takuji Torimura
- Organizer
  50^<th> Anniversary of the CINVESTAV
- Place of Presentation
  Mexico-city, MEXICO(招待講演)
- Year and Date
  2011-11-16
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] マウス肝癌モデルにおけるAfliberceptの血管形成抑制機序に関する検討2011
- Author(s)
  鳥村拓司
- Organizer
  第43回日本臨床分子形態学会総会・学術集会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] マウス肝癌モデルにおけるAfliberceptの血清形成抑制機序に関する検討2011
- Author(s)
  鳥村拓司
- Organizer
  第47回日本肝臓学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] マウス肝癌モデルにおけるAfliberceptの血清形成抑制機序に関する検討.2011
- Author(s)
  鳥村拓司
- Organizer
  第47回日本肝臓学会総会
- Place of Presentation
  東京都
- Year and Date
  2011-06-23
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Antiangiogenic mechanisms of aflibercept in mouse hepatoma model2011
- Author(s)
  Takuji Torimura
- Organizer
  102nd Annual Meeting of the American Association for Cancer Research (AACR)
- Place of Presentation
  Orland, USA
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Antiangiogenic mechanisms of aflibercept of a mouse hepatoma modelantiangiogenic mechanisms of aflibercept of a mouse hepatoma model2011
- Author(s)
  Takuji Torimura
- Organizer
  The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Place of Presentation
  San Francisco, USA
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] 肝細胞癌を用いた作用機序の異なる血管新生阻害療法の比較:メトロノミックケモラピーとVEGFR-2リン酸化阻害剤の比較.2011
- Author(s)
  岩本英希、鳥村拓司.
- Organizer
  第47回日本肝臓学会総会
- Place of Presentation
  東京都
- Year and Date
  2011-06-23
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Antiangiogenicmechanisms of aflibercept in mouse hepatoma model.2011
- Author(s)
  Torimura Takuji
- Organizer
  102nd Annual Meeting of the American Association for CancerResearch
- Place of Presentation
  オーランド、アメリカ
- Year and Date
  2011-04-26
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] マウス肝癌でのAfliberceptの血管新生抑制機序に関する検討2011
- Author(s)
  鳥村拓司
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Low dosemetronomic chemotherapy of S-1 and Vandetanib produces nontoxically good therapeutic results forhepatocellular carcinoma (HCC).2010
- Author(s)
  Iwamoto H, Torimura T.
- Organizer
  101stAnnual Meeting of the American Association for Cancer Research.
- Place of Presentation
  ワシントン、アメリカ
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] StageIV-A肝細胞癌症例に対する長期予後を目標とした集学的治療.2010
- Author(s)
  永松洋明、鳥村拓司
- Organizer
  第96回日本消化器病学会総会.
- Place of Presentation
  山形市
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Mechanisms of anti-angiogenic effect of aflibercept for hepatocellular carcinoma in mice2010
- Author(s)
  鳥村拓司
- Organizer
  日本癌学会
- Place of Presentation
  大阪
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Effect of metronomic chemotherapy with S-1+vandetanib in a mouse model of hepatocellular carcinoma.2010
- Author(s)
  Takuji torimura, Hideki Iwamoto, et al.
- Organizer
  AASLD
- Place of Presentation
  Boston
- Year and Date
  2010-11-01
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] マウス肝癌におけるAfliberceptの血管形成抑制機序に関する検討2010
- Author(s)
  鳥村拓司
- Organizer
  第24回肝類洞壁細胞研究会
- Place of Presentation
  福島市
- Data Source
  KAKENHI-PROJECT-22590752
[Presentation] Antiangiogenic therapy for HCC by inhibiting VEGF2009
- Author(s)
  鳥村拓司
- Organizer
  4th anniversary symposium of Yonseiliver cancer special clinic
- Place of Presentation
  Seoul
- Year and Date
  2009-06-13
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] VEGF Trap(Aflibercept)によるマウス肝癌の増殖抑制機序に関する検討肝類洞壁細胞研究会2009
- Author(s)
  鳥村拓司
- Place of Presentation
  大阪
- Year and Date
  2009-12-13
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] Mechanisms of anti-angiogenic effect of VEGF Trap(Aflibercept)for hepatocellular carcinoma in mice2009
- Author(s)
  鳥村拓司
- Organizer
  日本癌学会
- Place of Presentation
  横浜
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] New advances of non-surgical treatment of hepatocellular carcinoma2009
- Author(s)
  鳥村拓司
- Organizer
  Konyang International Digestive Disease Symposium 2009
- Place of Presentation
  Daejeon
- Year and Date
  2009-04-12
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] Mechanisms of anti-angiogenic effect of VEGF Trap (Aflibercept) for hepatocellular carcinoma in mice2009
- Author(s)
  Torimura T.
- Organizer
  AASLD
- Place of Presentation
  Boston
- Year and Date
  2009-11-02
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] Mechanisms of anti-angiogenic effect of VEGF Trap(Aflibercept)for hepatocellular carcinoma in mice2009
- Author(s)
  鳥村拓司
- Organizer
  AACR
- Place of Presentation
  Denver
- Year and Date
  2009-04-19
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] VEGF Trap(Aflibercept)によるマウス肝癌の増殖抑制機序に関する検討2009
- Author(s)
  鳥村拓司
- Organizer
  日本肝臓学会総会
- Place of Presentation
  神戸
- Year and Date
  2009-06-04
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] Mechanisms of anti-angiogenic effect of VEGF Trap(Aflibercept)for hepatocellular carcinoma in mice2009
- Author(s)
  鳥村拓司
- Organizer
  ILCA
- Place of Presentation
  Milan
- Year and Date
  2009-09-05
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] Mechanisms of anti-angiogenic effect of VEGF Trap(Aflibercept)for hepatocellular carcinoma in mice2009
- Author(s)
  鳥村拓司
- Organizer
  AASLD
- Place of Presentation
  Boston
- Year and Date
  2009-11-02
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] 肝細胞がんの治療2009
- Author(s)
  鳥村拓司
- Organizer
  日本消化器病学会東北支部例会
- Place of Presentation
  福嶋
- Year and Date
  2009-07-10
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] マウス肝癌における Aflibercept の血管形成抑制機序に関する検討2009
- Author(s)
  鳥村拓司
- Organizer
  浜名湖シンポジウム
- Place of Presentation
  浜松
- Year and Date
  2009-12-22
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] VEGF Trap suppresses tumor growth of hepatocellular carcinoma in mice mediated by the inhibition of angiogenesis and vasculogenesis.2008
- Author(s)
  Torimura T.
- Organizer
  AASLD
- Place of Presentation
  Boston
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] VEGF Trap (Aflibercept) suppresses tumor growth of hepatocellular carcinoma in mice mediated by the inhibition of angiogenesis and vasculogenesis.2008
- Author(s)
  T. Torimura
- Organizer
  AASLD
- Place of Presentation
  America(アメリカ合衆国)
- Year and Date
  2008-11-02
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] VEGF Trap suppresses tumor growth of hepatocellular carcinoma in mice2008
- Author(s)
  Torimura T.
- Organizer
  日本癌学会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] 5-FU SECRETED BY ENDOTHELIAL PROGENITOR CELLS WITH CYTOSINE DEAMINASE IN TUMOR SUPPRESSES GROWTH OF HEPATOMA.2007
- Author(s)
  Torimura T.
- Organizer
  日本癌学会
- Place of Presentation
  横浜
- Year and Date
  2007-10-03
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] SELECTIVE HOMING OF ENDOTHELIAL PROGENITOR CELLS WITH CYTOSINE DEAMINASE cLINA TO TUMOR TISSUES SUPPRESSES GROWTH OF HEPATOCELLULAR CARCINOMA BY 5-FLUOROURACIL SECRETION2007
- Author(s)
  T.Torimura
- Organizer
  AASLD
- Place of Presentation
  Boston,USA
- Year and Date
  2007-11-04
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] SELECTIVE HOMING OF ENDOTHELIAL PROGENITOR CELLS WITH CYTOSINE DEAMINASE cDNA TO TUMOR TISSUES SUPPRESSES GROWTH OF HEPATOCELLULAR CARCINOMA BY 5-FLUOROURACIL SECRETION.2007
- Author(s)
  Torimura T.
- Organizer
  AASLD
- Place of Presentation
  SF
- Year and Date
  2007-10-30
- Data Source
  KAKENHI-PROJECT-19590796
[Presentation] 肝癌での腫瘍血管形成における骨髄細胞の関与に関する検討
- Author(s)
  鳥村拓司、上野隆登、中村　徹、古賀浩徳、安倍満彦、池園　友、増田　裕、矢野博久、佐田通夫
- Organizer
  第45回日本臨床分子形態学会総会・学術集会
- Place of Presentation
  アクロス福岡
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] A novel synthetic sulfoglycolipid sulfoqunovosylacyl-propanediol (SQAP) switches off tumor angiogenic potential of hepatocellular carcinoma through the upregulation of von hippel-lindau protein
- Author(s)
  Iwamoto H, Torimura T, Ohta K, Koga H, Nakamura T, Abe M, Masuda H, Yano H, Sata M
- Organizer
  The 48th Annual Meeting of the European Association for the Study of the Liver (EASL)
- Place of Presentation
  RAI Convention Centre（Amsterdam, The Netherlands）
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] 腫瘍von Hippel-Lindau蛋白を標的とした新規血管新生阻害剤SQAPの肝細胞癌に対する効果の基礎的検討
- Author(s)
  岩本英希、中村徹、安倍満彦、池園友、和田史孝、黒松亮子、田尻能祥、矢野博久、古賀浩徳、鳥村拓司
- Organizer
  第51回日本肝臓学会
- Place of Presentation
  熊本
- Year and Date
  2015-05-21 – 2015-05-22
- Data Source
  KAKENHI-PROJECT-25461018
[Presentation] 肝細胞癌に対する血管新生抑制療法の試み．
- Author(s)
  鳥村拓司
- Organizer
  第67回久留米医学会総会
- Place of Presentation
  久留米市
- Invited
- Data Source
  KAKENHI-PROJECT-22590752

1. UENO Takato (70176618)

# of Collaborated Projects: 12 results

# of Collaborated Products: 9 results
2. NAKAMURA Touru (30341332)

# of Collaborated Projects: 6 results

# of Collaborated Products: 23 results
3. KOGA Hironori (90268855)

# of Collaborated Projects: 5 results

# of Collaborated Products: 51 results
4. INUZUKA Sadataka (80193572)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
5. TANIGUCHI Eitaro (50341318)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
6. HARADA Riko (50279155)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
7. SAKAMOTO Masaharu (60248367)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. GONDO Kazuhisa (00186909)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. HASHIMOTO Osamu (50289427)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. 金基哲 (30279145)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. 岩本英希 (40529541)

# of Collaborated Projects: 2 results

# of Collaborated Products: 58 results
12. NAKASHIMA Emi (90115254)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. TANIKAWA Kyuichi (10080649)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. TAMAKI Seishu (00258443)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. SAKATA Ryuichiro (70258424)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. HARADA Masaru (00241175)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
17. OKAMURA Takashi (30136436)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 木村利奈 (60299518)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 川口巧 (00320177)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 矢野博久 (40220206)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
21. 山本健 (60274528)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
22. 光山慶一 (20200066)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. 村上卓道

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Torimura Takuji 鳥村 拓司

TORIMURA Takuji 鳥村 拓司

島村 拓司 シマムラ タクジ

Research Projects

Research Products

Co-Researchers

The investigation of factors influencing on therapeutic effect of anti-PD-1 antibody therapy for hepatocellular carcinoma by comprehensive analysis of intestinal floraPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

DNA methylation level of 10 CpG sites on 8 specific genes in non-cancerous liver tissues is useful to predict multicentric recurrence of hepatocellular carcinoma after surgical resectionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of new antiangiogenic therapy specific for tumor tissue of hepatocellular carcinoma with microRNAPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of iPS cells-derived vector cells for antiangiogenic gene therapy for hepatocellular carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Antiangiogenic gene therapy for hepatocellular carcinoma with bone marrow-derived progenitor cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research for usefulness of intestinal peptide, PYY_<3-36> for therapeutic agents of fatty liver and NASH

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene Transfer of Endostatin cDNA to Bone Marrow Cells of Mice with Hepatocellular CarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Biological significance of the expression of a Wilson disease mutant protein

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

ROLE OF PPARα HUMAN HEPATIC STELLATE CELL AND HEPATOMA CELL

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of Angiopoietin-1,2, and Tie-2 on angiogenesis in hepatocellular carcinoma.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene transfer of Endostatin and K1-5 suppresses the growth of hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Inhibitory effect of the angiogenesis inhibitor TNP-470 on hepatocellular carcinomasPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of cells and peptides controling the hepatic sinusoidal blood flow

Principal Investigator

Torimura Takuji 鳥村拓司

TORIMURA Takuji 鳥村拓司

島村拓司シマムラタクジ